SFG Wealth Management LLC. Has $251,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SFG Wealth Management LLC. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.6% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 507 shares of the medical equipment provider’s stock after acquiring an additional 100 shares during the period. SFG Wealth Management LLC.’s holdings in Intuitive Surgical were worth $251,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Onefund LLC boosted its stake in shares of Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after buying an additional 18 shares during the last quarter. AlphaCore Capital LLC increased its position in shares of Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock valued at $235,000 after purchasing an additional 18 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of Intuitive Surgical by 2.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider’s stock worth $390,000 after buying an additional 19 shares during the last quarter. Accredited Investors Inc. raised its position in Intuitive Surgical by 1.9% in the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider’s stock worth $543,000 after acquiring an additional 19 shares during the period. Finally, Second Line Capital LLC increased its stake in shares of Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider’s stock worth $302,000 after purchasing an additional 19 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 215 shares of the business’s stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at $970,738.08. The trade was a 10.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares of the company’s stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock worth $2,611,577 over the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.3%

Intuitive Surgical stock opened at $521.63 on Thursday. The business’s fifty day simple moving average is $530.03 and its two-hundred day simple moving average is $536.86. The company has a market capitalization of $186.96 billion, a price-to-earnings ratio of 76.49, a price-to-earnings-growth ratio of 5.55 and a beta of 1.67. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same period in the prior year, the firm posted $1.50 EPS. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research reports. Piper Sandler lowered their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Barclays reduced their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. Robert W. Baird dropped their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. Finally, BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.